<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Trials id="330221"><Title>To Assess the Relative Bioavailability (BA) of TRIUMEQ and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers</Title><Indications><Indication>HIV infection</Indication></Indications><Phase>Phase 1 Clinical</Phase><Drugs><Drug>dolutegravir + lamivudine + abacavir (HIV), ViiV</Drug></Drugs><RecruitmentStatus>Completed</RecruitmentStatus><Sponsor>ViiV Healthcare Ltd</Sponsor></Trials>